Angelman Biomarkers

Official twitter for A-BOM: Angelman Biomarkers & Outcomes Measures Alliance
#angelman #biomark #ABOM

[Angelman Biomarkers @AngelmanBiomark]

Enroll your loved ones in #angelmansyndrome studies today! #research #cureangelman #findacure #rarediseases
https://t.co/RQd611wYAK
https://t.co/O4oPp3PS9u … …
@cureangelman @angelman @RareDiseases @angelmantoday @fastercures @RareAction

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala https://t.co/AXLFggEOpD AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: 20-Year Mystery of Girl with Angelman and 2nd Rare Disease Solved via Genetic Testing https://t.co/1zMeE3u98x AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Eurordis Unveils Integrated-care Initiative for Rare Disease Patients https://t.co/QMk5E7HMlr AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: ‘Rare Barometer’ Program Helps Eurordis Shape EU Rare Disease Policy https://t.co/MlNUbcs10k AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Familiarity Is the Foundation for Acceptance https://t.co/qS0mJom5pw AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Scientists Develop Quick, Accurate Diagnostic Test for Angelman and Prader-Willi Syndromes https://t.co/ZDL8wagFuH AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Agency Unveils RaDaR to Help Patient Groups Develop Rare Disease Registries https://t.co/zZ3hTLTq1t AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Roche Researcher Plans Clinical Trial Seeking Ways to Measure Disease Impact in Home and Clinic https://t.co/k9H1QG7wZ4 AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: #AANAM – OV101 Improves Motor Function, Sleep, Behavior, Phase 2 Trial Shows https://t.co/x69W3Y4POV AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Hyperactivity, Irritability and Outbursts in Children with Angelman Cause Stress for Parents, Study Finds https://t.co/tqv26zE70P AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Rare Diseases Constitute a ‘Public Health Issue,’ NCATS Director Warns https://t.co/ItNDNcclrC AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Angelman on the Trail https://t.co/NgWsdAQad1 AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: EpiSign Blood Test Helps Make Accurate Diagnosis of Angelman, Other Diseases https://t.co/2taLzLgi6S AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Neurological Deficits of Angelman May Depend on microRNA Deficiency https://t.co/TGLgszlqCR AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Reactivating UBE3A May Reverse Changes in Brain in Angelman Syndrome, Study In Mice Shows https://t.co/0QMuBCSgHs AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: I’m Learning to Encourage Active Listening https://t.co/vqcGWvORtn AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Germline Mosaicism Linked to Angelman Syndrome in 2 Siblings for 1st Time, Researchers Say https://t.co/ubxMVn21H7 AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Angels Are Clever and Sneaky https://t.co/dwPfPVJ9f6 AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Study Finds Differences in Brain Activity Based on Genotype in Angelman Patients https://t.co/sxD0XtQHi8 AngelmanSyndromeNews

[Angelman Biomarkers @AngelmanBiomark]

Update from ASN: Fundraising and the Butterfly Effect https://t.co/vbJAocf9Cs AngelmanSyndromeNews